Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
1020719-20-3CC(C)C(=O)/C(=C/c1ccccc1)C(=O)Nc1ccc(OCc2ccccc2)cc1FCQZYAJFAUTKRU-ULJHMMPZSA-N1020719-20-3VerwendenA deuterated intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.